Keywords: bioprogress, fails, break, even, uk, provider, delivery

BioProgress fails to break even in 2003

Article | 15 March 2004

Print This

The UK's BioProgress, a provider of delivery mechanisms for the pharmaceutical oral dosage markets, has reported a pretax net loss ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in